Lymphoma Knowledge Hub

CDH23 May Play a Key Role in DLBCL Tumorigenesis

Cadherin-23(CDH23) is correlated with diffuse large B-cell lymphoma (DLBCL) tumor formation, according to a study published in Aging. To conduct this study, researchers used the...

Examining the Grey-Zone Between DLBCL Lymphoma and Classical Hodgkin Lymphoma

There exists a grey-zone in lymphoma, which makes the diagnosis between classical Hodgkin lymphoma and diffuse large B-cell lymphoma (DLBCL) hard to discern, according...

Comparing the Prognostic Impact of Six Versus Eight Cycles of R-CHOP in DLBCL

There is no difference in efficacy between six and eight cycles of R-CHOP-21 to treat diffuse large B-cell lymphoma (DLBCL), according to a study...
purple cells viewed under a microscope

Assessing Quantitative Radiomic Features in DLBCL

A study found no discernable difference in the discrimination capability of radiomic features, which may predict diffuse large B-cell lymphoma (DLBCL) outcomes, and different...
Risk management concept. The meeting at the white office table.

A Risk Model and Nomogram to Help in DLBCL Prediction and Prognosis

Researchers developed a risk model to better help predict the prognosis of diffuse large B-cell lymphoma (DLBCL). The findings were published in Expert Review...
Writing note showing Predictive Analytics. Business photo showcasing Optimize Collection Achieve CRMIdentify Customer.

Novel Immune-Related Prognostic Classifier with Robust Predictive Power in DLBCL

A novel immune-related gene (IRG) classifier demonstrates robust predictive capabilities in diffuse large B cell lymphoma (DLBCL), according to a study published in the...
3d illustration Cancer cell

Assessing Genetic Variants that Impact the prognosis of DLBCL

Diffuse large B-cell lymphoma (DLBCL) patients have gene features that modulate their prognosis and response to R-CHOP therapy, according to a study published in...

Journal Reading List